PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 61 filers reported holding PTC THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 1.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,194,407 | -53.6% | 53,298 | -15.9% | 0.00% | -100.0% |
| Q2 2023 | $2,576,119 | +33.3% | 63,342 | +58.7% | 0.00% | 0.0% |
| Q1 2023 | $1,933,047 | +4330.7% | 39,906 | +3391.3% | 0.00% | – |
| Q4 2022 | $43,628 | -71.1% | 1,143 | -62.0% | 0.00% | – |
| Q3 2022 | $151,000 | -1.9% | 3,010 | -21.3% | 0.00% | – |
| Q2 2022 | $154,000 | -89.2% | 3,825 | -90.0% | 0.00% | – |
| Q1 2022 | $1,420,000 | -41.2% | 38,061 | -37.2% | 0.00% | -100.0% |
| Q4 2021 | $2,413,000 | +12.5% | 60,605 | +5.2% | 0.00% | – |
| Q3 2021 | $2,144,000 | +10.9% | 57,611 | +25.9% | 0.00% | – |
| Q2 2021 | $1,934,000 | -40.1% | 45,742 | -32.9% | 0.00% | -100.0% |
| Q1 2021 | $3,229,000 | -37.6% | 68,181 | -19.6% | 0.00% | 0.0% |
| Q4 2020 | $5,173,000 | +67.3% | 84,760 | +28.2% | 0.00% | 0.0% |
| Q3 2020 | $3,092,000 | -63.9% | 66,127 | -60.8% | 0.00% | -50.0% |
| Q2 2020 | $8,558,000 | +56.1% | 168,658 | +37.2% | 0.00% | 0.0% |
| Q1 2020 | $5,483,000 | +203.4% | 122,908 | +226.5% | 0.00% | – |
| Q4 2019 | $1,807,000 | +41.7% | 37,644 | -0.2% | 0.00% | – |
| Q3 2019 | $1,275,000 | -16.5% | 37,711 | +11.1% | 0.00% | – |
| Q2 2019 | $1,527,000 | -54.6% | 33,941 | -62.0% | 0.00% | -100.0% |
| Q1 2019 | $3,364,000 | +11.4% | 89,355 | +1.5% | 0.00% | 0.0% |
| Q4 2018 | $3,020,000 | +79.7% | 87,999 | +146.2% | 0.00% | – |
| Q3 2018 | $1,681,000 | -61.9% | 35,749 | -72.7% | 0.00% | -100.0% |
| Q2 2018 | $4,413,000 | +105.4% | 130,831 | +64.9% | 0.00% | 0.0% |
| Q1 2018 | $2,148,000 | +69.0% | 79,356 | +4.2% | 0.00% | – |
| Q4 2017 | $1,271,000 | +19.8% | 76,157 | +43.7% | 0.00% | – |
| Q3 2017 | $1,061,000 | +7.7% | 52,993 | -1.4% | 0.00% | – |
| Q2 2017 | $985,000 | +57.6% | 53,725 | -15.3% | 0.00% | – |
| Q1 2017 | $625,000 | -20.1% | 63,446 | -11.5% | 0.00% | – |
| Q4 2016 | $782,000 | +46.2% | 71,655 | +87.7% | 0.00% | – |
| Q3 2016 | $535,000 | +156.0% | 38,178 | +28.6% | 0.00% | – |
| Q2 2016 | $209,000 | +3.5% | 29,687 | -6.0% | 0.00% | – |
| Q1 2016 | $202,000 | -99.6% | 31,567 | -97.8% | 0.00% | -100.0% |
| Q4 2015 | $47,528,000 | -6.8% | 1,466,898 | -23.2% | 0.02% | -9.5% |
| Q3 2015 | $51,012,000 | -33.5% | 1,910,531 | +19.9% | 0.02% | -30.0% |
| Q2 2015 | $76,688,000 | -36.8% | 1,593,360 | -20.1% | 0.03% | +25.0% |
| Q1 2015 | $121,398,000 | +565.0% | 1,995,016 | +465.8% | 0.02% | +242.9% |
| Q4 2014 | $18,254,000 | +898.6% | 352,615 | +748.7% | 0.01% | +600.0% |
| Q3 2014 | $1,828,000 | +1887.0% | 41,548 | +1068.4% | 0.00% | – |
| Q2 2014 | $92,000 | +9.5% | 3,556 | +9.8% | 0.00% | – |
| Q1 2014 | $84,000 | +64.7% | 3,239 | +8.0% | 0.00% | – |
| Q4 2013 | $51,000 | -91.7% | 3,000 | -89.6% | 0.00% | – |
| Q3 2013 | $617,000 | – | 28,733 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 161,083 | $9,831,000 | 7.49% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 333,000 | $20,323,000 | 5.55% |
| RTW INVESTMENTS, LP | 4,221,836 | $257,659,000 | 4.32% |
| GEORGE KAISER FAMILY FOUNDATION | 90,011 | $10,766,000 | 2.85% |
| SECTORAL ASSET MANAGEMENT INC | 603,978 | $36,861,000 | 2.60% |
| Redwood Investments, LLC | 364,837 | $22,266,000 | 1.90% |
| ARMISTICE CAPITAL, LLC | 716,000 | $43,697,000 | 1.49% |
| CM Management, LLC | 25,000 | $1,526,000 | 1.42% |
| Third Security, LLC | 237,015 | $14,465,000 | 1.32% |
| Sofinnova Investments, Inc. | 316,478 | $19,315,000 | 1.15% |